Martin Schüler
German Cancer Research Center(DE)Heidelberg University(DE)National Center for Tumor Diseases(DE)Essen University Hospital(DE)German Marine Research Consortium(DE)West German Heart and Vascular Center Essen(DE)University of Duisburg-Essen(DE)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Colorectal Cancer Treatments and Studies, Lung Cancer Research Studies, HER2/EGFR in Cancer Research, Peptidase Inhibition and Analysis
Most-Cited Works
- → Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations(2013)3,181 cited
- → Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial(2019)2,482 cited
- → Comprehensive genomic profiles of small cell lung cancer(2015)2,338 cited
- → Direct Activation of Bax by p53 Mediates Mitochondrial Membrane Permeabilization and Apoptosis(2004)2,031 cited
- → Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations(2015)1,714 cited
- → Sotorasib for Lung Cancers with KRAS p.G12C Mutation(2021)1,682 cited